glp 1 agonists with cardiovascular benefit The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management | Current Risk Reports The Cardiovascular Physiology of Glucagon-like
Description
Early reports on small-molecule GLP-1 agents and novel formulations are emerging
GLP-1R expression spans multiple neuroanatomical domains including the basal ganglia (caudate, putamen, globus pallidus), limbic system (amygdala, hippocampus), hypothalamic nuclei, cerebellum, and spinal cord 69
however, the potential for weight loss with the GLP-1 incretin mimetics can be a motivator for some patients
McGowan BM, Bruun JM, Capehorn M, Pedersen SD, Pietilinen KH, Muniraju HAK, et al
Introduction into the global market has not yet been announced, so it is unclear where that supply will be produced.
